Clinical Trial Update: Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer [NA]

View source ↗

Summary

Clinical trial update for MRI-guided stereotactic ablative radiotherapy (MRI-SABR) in early-stage glottic laryngeal cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glottic Cancer
• Laryngeal Cancer

Snippet

Sponsor: Viktoras Rudzianskas | Conditions: Laryngeal Neoplasm, Glottic Carcinoma | NA | Status: RECRUITING